Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension

Journal of Internal Medicine

Volumn 240, Issue 4, 1996, Pages 233-242

  Ligtenberg, J J M ^a   Van Tol, A ^b   Van Haeften, T W ^a,c   Sluiter, W J ^a   Reitsma, W D ^a   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acyltransferase; Cholesteryl ester transfer protein; Free fatty acids; Hypertension; Lecithin:cholesterol; Lipoprotein; Triglycerides

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0029958036     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.47870000.x     Document Type: Article

References (52)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
2. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991; 14: 195-202.
3. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
4. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YDI, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580-3.
5. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 1994; 37: 948-52.
6. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arterioscler Thromb 1990; 10: 223-31.
7. Despres J. Dyslipidaemia and obesity. Baillieres Clin Endocrinol Metab 1994. pp 629-54.
8. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-74.
9. Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73: I40-50.
10. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22.
11. Shieh SM, Shen M, Fuh MM, Chen YDI, Reaven GM. Plasma lipid and lipoprotein concentrations in Chinese males with coronary artery disease, with and without hypertension. Atherosclerosis 1987; 67: 49-55.
12. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 1985; 5: 391-6.
13. Dobiasova M, Stribrna J, Haydn Pritchard P, Frohlich JJ. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res 1992; 33: 1411-8.
14. Fuh MM, Shieh SM, Wu DA, Chen YD, Reaven GM. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 1987; 147: 1035-8.
15. Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992; 82: 1-8.
16. Dashti N, Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 1987; 28: 423-36.
17. McKeigue PM, Laws A, Chen YD, Marmot MG, Reaven GM. Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterifled fatty acids. Possible explanation for sex differences in lipoprotein pattern. Arterioscler Thromb 1993; 13: 1187-92.
18. Byrne CD, Wareham NJ, Brown DC, Clark PM, Cox LJ. Day NE et al. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance : relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 1994; 37: 889-96.
19. Lewis GF, Uffelman KD, Szeto AW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95: 158-66.
20. Swislocki ALM, Tsuzuki A. Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat. Am J Med Sci 1993; 306: 282-6.
21. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 2: 419-23.
22. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017-58.
23. Dullaart RPF, Groener JE, Erkelens DW. Cholesterylester transfer between lipoproteins. Diab Nutr Metab 1991; 4: 329-43.
24. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
25. Zechner R, Dieplinger H, Steyrer E, Groener J, Calvert D, Kostner GM. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin: cholesterol acyltransferase and cholesterol ester transfer protein. Biochim Biophys Acta 1987; 918: 27-35.
26. Dullaart RPF, Gansevoort RT, Dikkeschei LD, de Zeeuw D, de Jong PE, Van Tol A. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993; 44: 91-7.
27. Dullaart RPF, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus - its relationship with serum lipids. Diabetologia 1989; 32: 14-9.
28. Zhao S, Smelt AHM, Van den Maagdenberg AMJM, Van Tol A, Vroom TFFP, Van der Laarse A et al. Plasma lipoprotein profiles of normocholesterolemic homozygotes for Apolipoprotein E2 (Arg158XCys) compared. Clin Chem 1994; 40: 1559-66.
29. Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-94.
30. Aral T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S et al. Increased plasma cholesteryl ester transfer protein in obese subjects. Arterioscler Thromb 1994; 14: 1129-36.
31. Sutherland WHF, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994; 43: 1362-6.
32. Kahri J, Syvanne M, Taskinen MR. Plasma cholesteryl transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 1994; 43: 1498-502.
33. Van Haeften TW, Boonstra E, Veneman TF, Gerich JE, Van der Veen EA. Dose-response characteristics for glucose-stimulated insulin release in man and the assessment of influence of glucose on arginine stimulated insulin release. Metabolism 1990; 39: 1292-9.
34. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
35. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 1992; 75: 379-82.
36. Glomset JA, Wright JL. Some properties of a cholesterol esterifying enzyme in human plasma. Biochem Biophys Acta 1964; 89: 266-76.
37. Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283-6.
38. Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737-44.
39. Floren C, Chen C, Franzen J, Albers JJ. Lecithin-cholesterol acyl-transferase in liver disease. Scand J Clin Invest 1987; 47: 613-7.
40. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168-73.
41. Chen YD, Golay A, Swislocki ALM, Reaven GM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 17-21.
42. Yki-Jarvinen H. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 1988; 37: 1271-8.
43. Byrne CD, Wareham NJ, Day NE, McLeish R, Williams DRR, Hales CN. Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance. Diabetologia 1995; 38: 1358-66.
44. Groop LC, Ferrannini E. Insulin action and substrate competition. Baillieres Cliin Endocrinol Metab 1993; 7: 1007-32.
45. Hunnicutt JW, Hardy RW, Williford J, McDonald JM. Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes 1994; 43: 540-5.
46. Cummings MH, Watts GF, Umpleby AM, Hennessy TR. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 1995; 38: 959-67.
47. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 853-4-2.
48. Yki-Jarvinen H, Taskinen MR, Nikkila EA. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 1984; 27: 364-9.
49. Barter PJ, Hopkins GJ, Rajaram OV. Enzymes involved in plasma cholesterol transport. Baillieres Clin Endocrinol Metab 1987; 1: 623-38.
50. Barter PJ, Hopkins GJ, Gorjatschko L, Jones ME. Competitive inhibition of plasma cholesterol esterification by human high-density lipoprotein-subfraction 2. Biochim Biophys Acta 1984; 793: 260-8.
51. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.
52. Eisenberg S. Preferential enrichment of large-sized very low density lipoproteins populations with transferred cholesteryl esters. J Lipid Res 1985; 26: 487-94.